Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001363763-14-000001
Filing Date
2014-03-20
Accepted
2014-03-20 18:52:50
Documents
1
Period of Report
2014-03-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4430
  Complete submission text file 0001363763-14-000001.txt   5775
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Issuer) CIK: 0000849636 (see all company filings)

EIN.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AURORA CAPITAL, LLC 17 PARK AVENUE, #201 NEW YORK NY 10016
Business Address
Lippa Arnold (Reporting) CIK: 0001363763 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16467 | Film No.: 14707839